Amneal Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $27.4M |
| FY2017 | $1.36B | $0 | $0 |
| FY2018 | $2.63B | $504.8M | $213.4M |
| FY2019 | $2.61B | $232.0M | $151.2M |
| FY2020 | $2.74B | $303.3M | $341.4M |
| FY2021 | $2.68B | $360.3M | $247.8M |
| FY2022 | $2.59B | $298.4M | $26.0M |
| FY2023 | $2.39B | $19.8M | $91.5M |
| FY2024 | $2.16B | $-109.3M | $110.6M |
| FY2025 | $2.57B | $-70.8M | $282.0M |